...
首页> 外文期刊>Contemporary Clinical Dentistry >A randomized control trial comparing buccal infiltration of 4% articaine with buccal and palatal infiltration of 2% lignocaine for the extraction of maxillary premolar teeth
【24h】

A randomized control trial comparing buccal infiltration of 4% articaine with buccal and palatal infiltration of 2% lignocaine for the extraction of maxillary premolar teeth

机译:一项比较4%青蒿素的颊侧浸润与2%利多卡因的颊侧和in侧浸润的上颌前磨牙拔牙的随机对照试验

获取原文
           

摘要

Introduction: The use of articaine has been claimed to obviate the need for routine palatal local anesthetic injections on account of its better diffusion through soft and hard tissues as compared to other local anesthetic agents. Objective: The objective of the study is to evaluate the efficacy of 4% articaine (with 1:100,000 adrenaline) infiltrated only buccally in the extraction of maxillary premolars for orthodontic reasons. Materials and Methods: A double-blind randomized clinical trial with a split-mouth design, where each patient (n = 100) was part of two groups, was conducted. Experimental Group 1: single buccal infiltration of 4% articaine with 1:100,000 adrenaline (Septanest? with adrenaline 1:100,000 by Septodont). Control Group 2: routine buccal and palatal infiltrations of 2% lignocaine with 1:200,000 adrenaline (Lox? 2% with adrenaline 1:200,000 by Neon). The parameters studied were time to onset of anesthesia, pain during the extraction procedure (not during the injecting of the local anesthetic), and frequency of extra amount of local anesthetic injected. Results: The difference was not statistically significant (P 0.05) between the two groups with respect to all three parameters. This proves that a single buccal infiltration of articaine can be used as an alternative to lignocaine for the extraction of the maxillary premolar teeth in most of the cases. Conclusion: This proves that a single buccal infiltration of articaine can be used as an alternative to lignocaine for the extraction of the maxillary premolar teeth in most of the cases.
机译:简介:由于与其他局部麻醉剂相比,其在软,硬组织中的扩散性更好,因此已宣布使用青蒿素可避免常规pa上局部麻醉剂的注射。目的:本研究的目的是评估由于正畸原因仅经颊部浸润的4%青蒿素(含1:100,000肾上腺素)在拔除上颌前磨牙中的疗效。材料和方法:采用双口设计的双盲随机临床试验,每个患者(n = 100)是两组的一部分。实验组1:通过Septondont用1:100,000肾上腺素单颊浸润4%青蒿素(Septanest?和肾上腺素1:100,000)。对照组2:常规的含1%至200,000肾上腺素的2%利多卡因的颊和pa浸润(Neon的Lox?2%含肾上腺素的比例为1:200,000)。研究的参数是麻醉开始的时间,提取过程中的疼痛(不在局部麻醉药注射期间)以及过量局部麻醉药注射的频率。结果:就所有三个参数而言,两组之间的差异无统计学意义(P> 0.05)。这证明在大多数情况下,一次青蒿素的颊颊浸润可作为木乃伊卡因的替代品,用于提取上颌前磨牙。结论:这证明在大多数情况下,一次青蒿素的颊颊浸润可以替代木乃卡因来拔除上颌前磨牙。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号